----------------------------------------------
------------------------------------------------------------------
Medical News Today posted an article regarding a new study that was done with mice. This is not uncommon in the field of brain tumor research, especially when you take into account that there has been tremendous success in the past. With great results found in these creatures, it has been likely that humans could benefit in similar fashions. After seeing what exactly this particular study had to offer, I was pleasantly surprised with the results in question and the potential that they have for the future.
The report in question talked about how workers at the John Hopkins University School of Medicine have been able to go about research with a new drug brought into effect. The drug has been referred to as 5-azacytidine and it is one that can prove useful in the realm of brain tumor research. After all, this has been able to be brought into effect in a pre-leukemia condition. There have been strong results seen thanks to this usage, which can be looked into by organizations like Voices against Brain Cancer.
Gliomas - seen as the most common and rapidly growing tumors in the brain - are going to be helped thanks to this drug. In particular, the drug will be able to target the mutation referred to simply as IDH1. For those of you who are unfamiliar with what exactly this entails, it is an alteration that is seen in 70 to 80 percent of all lower-grade tumors in patient. This mutation will make it impossible for the body to utilize protein for the sake of transitioning glucose into energy.
The study went on for a period of 14 weeks and the impact of 5-azacytidine had proven itself to be, to say the least, beneficial. Tumor growth in mice went down tremendously and a relapse did not occur since that point. It didn't even stop seven weeks after the use of the drug in question had been stopped. I do not think that you need me to tell you that this is extremely beneficial for those who have seen difficulties in terms of therapies and tumor regression.
It's difficult to predict when tumor regression is going to be seen in different studies but the truth of the matter is that it happened here. I don't think you need me to tell you just how important this is to brain tumor research efforts. Mice were treated well as the progression of their growths had been reduced and I have to believe that humans will be able to benefit from this process as well. It's just a matter of time as studies are undoubtedly going to be shifted.
The report in question talked about how workers at the John Hopkins University School of Medicine have been able to go about research with a new drug brought into effect. The drug has been referred to as 5-azacytidine and it is one that can prove useful in the realm of brain tumor research. After all, this has been able to be brought into effect in a pre-leukemia condition. There have been strong results seen thanks to this usage, which can be looked into by organizations like Voices against Brain Cancer.
Gliomas - seen as the most common and rapidly growing tumors in the brain - are going to be helped thanks to this drug. In particular, the drug will be able to target the mutation referred to simply as IDH1. For those of you who are unfamiliar with what exactly this entails, it is an alteration that is seen in 70 to 80 percent of all lower-grade tumors in patient. This mutation will make it impossible for the body to utilize protein for the sake of transitioning glucose into energy.
The study went on for a period of 14 weeks and the impact of 5-azacytidine had proven itself to be, to say the least, beneficial. Tumor growth in mice went down tremendously and a relapse did not occur since that point. It didn't even stop seven weeks after the use of the drug in question had been stopped. I do not think that you need me to tell you that this is extremely beneficial for those who have seen difficulties in terms of therapies and tumor regression.
It's difficult to predict when tumor regression is going to be seen in different studies but the truth of the matter is that it happened here. I don't think you need me to tell you just how important this is to brain tumor research efforts. Mice were treated well as the progression of their growths had been reduced and I have to believe that humans will be able to benefit from this process as well. It's just a matter of time as studies are undoubtedly going to be shifted.
About the Author:
Contact Voices Against Brain Cancer if you're looking for more information about brain cancer research.. Check here for free reprint license: Mice Treatment Results For Brain Tumor Research.
0 comments:
Post a Comment